AMG 655, TRAIL-R2 mAb, Human Anti-TNFRSF10B Recombinant Antibody
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. [1][2][3].
Molecular Weight:
(145.44 kDa)
Purity:
98.90
CAS Number:
[896731-82-1]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted